Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/29/14 → 4/29/17 |
Funding
- PPD Development (Protocol # 11-019)
- Portola Pharmaceuticals, Inc. (Protocol # 11-019)
Protocol # 11-019: Multicenter, Randomized, Active-Controlled Efficacy and Safety Study Comparing Extended Duration Betrixaban with Standard of Care Enoxaparin for the Preventive of Venous Thromboembolism in Acute Medically Ill Patients
- Ruff Treiber, Ilana Marie (PD/PI)
Project: Research project